The capillary electrophoresis market size is projected to be valued at US$ 1.0 billion in 2023 and is expected to rise to US$ 1.8 billion by 2033. The sales of capillary electrophoresis are expected to grow at a significant CAGR of 5.7% during the forecast period.
Capillary electrophoresis (CE) is a powerful analytical technique used in chemistry and biochemistry to separate and analyze charged particles based on their size and charge-to-mass ratio. It is commonly used for the analysis of small molecules, ions, proteins, nucleic acids, and other biomolecules.
The demand for CE was driven by expanding biotechnology and pharmaceutical industries, growing research in life sciences, and rising concerns for environmental safety. Technological advancements in CE technology also contributed to its popularity.
However, there are challenges, such as initial investment and maintenance costs, competition from other analytical techniques, and limitations in sample throughput. Despite these challenges, the market witnessed trends towards miniaturization and automation of CE systems, integration with mass spectrometry, and exploration for point-of-care applications in healthcare.
| Attribute | Details |
|---|---|
| Capillary Electrophoresis Market Estimated Size (2023) | US$ 1.0 billion |
| Capillary Electrophoresis Market CAGR (2023 to 2033) | 5.7% |
| Capillary Electrophoresis Market Forecasted Size (2033) | US$ 1.8 billion |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The capillary electrophoresis market witnessed a 6.8% CAGR from 2018 to 2022.
The market was primarily driven by the expanding applications of CE in various industries, such as pharmaceuticals, biotechnology, life sciences, and environmental analysis. Advancements in CE technology, including improved capillary coatings, enhanced detector sensitivity, and automation, further fueled market expansion.
2023 to 2033 Growth Forecast:
With the continuous evolution of drug development processes and personalized medicine, the demand for CE in the pharmaceutical industry is projected to increase further. Additionally, the emergence of novel biomolecular research and diagnostic techniques may likely boost the utilization of CE in proteomics, genomics, and molecular diagnostics.
Furthermore, the increasing focus on point-of-care applications and on-site analysis in healthcare settings may open new avenues for CE utilization. The trend of automation and miniaturization is expected to continue, enabling faster and more cost-effective analysis.
Growing Demand in Biotechnology and Pharmaceuticals: The biotechnology and pharmaceutical industries heavily rely on CE for drug development, quality control, and process optimization. CE's ability to analyze proteins, nucleic acids, and small molecules with high sensitivity and accuracy makes it an essential tool in these sectors.
Point-of-Care and Clinical Diagnostics: Integrating CE with point-of-care and clinical diagnostic applications enables rapid and on-site analysis of samples. CE's ability to provide quick results with minimal sample volumes is crucial in healthcare settings, supporting early disease detection and patient management.
Miniaturization and Automation: The trend towards miniaturization and automation of CE systems has made the technology more accessible and efficient. Smaller instruments with automated workflows allow faster analysis and reduced operational costs, making CE an attractive option for various research labs and industries.
Research in Personalized Medicine: The growing focus on personalized medicine and targeted therapies has increased the demand for advanced analytical tools like CE. It enables the characterization of individual patient samples, leading to more tailored and effective treatment approaches.
Principal Consultant
Standardization and Reproducibility: Any analytical technique must ensure consistent and reproducible results. In the case of CE, maintaining standardization across different instruments, laboratories, and operators can be challenging, impacting the reliability and comparability of data.
Interference from Matrix Effects: In some cases, matrix effects may affect CE analysis, where the sample matrix interferes with the separation or detection of analytes. Minimizing matrix effects is essential for accurate and reliable results.
Integration with Mass Spectrometry: While coupling CE with mass spectrometry can enhance detection capabilities, it also presents technical challenges in terms of interface compatibility, flow rates, and ionization efficiency.
Evolving Regulatory Landscape: As CE finds applications in pharmaceutical and clinical settings, regulatory compliance and validation become critical factors. Keeping up with changing regulatory guidelines can be demanding for industry stakeholders.
Genomic DNA to Witness a 5.6% CAGR During the Assessment Period
Capillary electrophoresis proved a valuable tool for researchers in genomics, genetics, and molecular biology, allowing them to study genetic variations, mutations, and markers. In clinical diagnostics, CE-based genetic testing aided in identifying genetic disorders and supporting personalized medicine. CE's accurate sizing and quantification of DNA fragments made it essential for next-generation sequencing (NGS) sample preparation. Additionally, it found applications in forensic DNA analysis, agriculture, and biotechnology.
Technological advancements in CE, such as improved capillary coatings and detector sensitivity, further enhanced the efficiency and accuracy of genomic DNA analysis. The integration of CE with mass spectrometry expanded the capabilities of DNA analysis, providing additional insights into complex samples.
Research Organizations and Institute to Grow at 5.5% Over the Analysis Period
Research organizations and institutes are significant capillary electrophoresis (CE) market end users. These institutions rely on CE technology for various research applications in various scientific disciplines. As key players in advancing knowledge and understanding in genomics, proteomics, molecular biology, and biotechnology, research organizations utilize CE to analyze DNA, proteins, and other biomolecules with high precision and resolution. CE's ability to separate and quantify analytes in complex samples is particularly valuable in studying genetic variations, mutations, and biomolecular interactions.
With its versatility, accuracy, and efficiency, capillary electrophoresis continues to be an indispensable tool in driving groundbreaking research and discoveries across diverse scientific disciplines.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The integration of CE with mass spectrometry and other advanced analytical techniques further enhances the capabilities of research organizations in characterizing and identifying biomolecules. Moreover, the flexibility and efficiency of CE empower United States researchers to tackle complex research challenges and drive groundbreaking discoveries. As the demand for accurate and reliable data analysis grows, the United States market for capillary electrophoresis is expected to witness steady expansion, contributing significantly to advancements in various scientific disciplines. With a robust CAGR of 5.6%, the United States CE market is poised to remain at the forefront of cutting-edge research and innovation throughout the forecast period.
With a projected market size of US$ 66.6 million by the end of the forecast period in 2033 and an impressive Compound Annual Growth Rate (CAGR) of 5.4% from 2023 to 2033, the United Kingdom market is witnessing steady expansion.
Research organizations, institutes, and biotechnology companies in the UK are actively adopting CE technology for various scientific applications. CE's high-resolution capabilities and precise analysis of DNA, proteins, and biomolecules contribute to genomics, proteomics, and molecular biology research advancements.
The government's support for scientific advancements, coupled with a skilled workforce, contributes to the robust growth of the CE market in the United Kingdom. As the country continues to invest in research and innovation, the capillary electrophoresis market is poised to remain dynamic and progressive, making a valuable impact on scientific discoveries and advancements in various scientific disciplines.
The market has witnessed steady progress, with a notable Compound Annual Growth Rate (CAGR) of 6.6% from 2018 to 2022. Looking ahead, the CAGR is expected to remain robust at 5.6% from 2023 to 2033.
Japanese research organizations, academic institutions, and biotechnology companies actively embrace CE technology for diverse scientific applications. The country's dedication to scientific advancements and the exploration of innovative applications may continue to drive the capillary electrophoresis market's success in Japan throughout the forecast period and beyond. With such impressive growth prospects, Japan stands as a key player in propelling scientific discoveries and advancements in various scientific domains through capillary electrophoresis technology.
The competitive landscape in the capillary electrophoresis (CE) market is characterized by several prominent players vying for market share. These companies offer a wide range of CE instruments, consumables, and related services to cater to diverse end-user needs. Some of the key players in the CE market include:
Agilent Technologies, Inc.: A leading global provider of analytical solutions, Agilent offers a comprehensive portfolio of CE systems with advanced features and high-performance capabilities. Their instruments are widely used in life sciences, pharmaceuticals, and biotechnology research.
Bio-Rad Laboratories, Inc.: Known for its expertise in life science research and diagnostics, Bio-Rad provides CE systems designed for precise DNA and protein analysis. Their innovative technologies contribute to advancements in genomics and proteomics research.
Thermo Fisher Scientific, Inc.: A key player in the life sciences and analytical instruments industry, Thermo Fisher offers a diverse range of CE platforms and consumables for various applications, including DNA sequencing and protein analysis.
SCIEX (a Danaher Corporation company): SCIEX specializes in mass spectrometry and CE technologies, offering integrated solutions for advanced biomolecule analysis and proteomics research.
PerkinElmer, Inc.: PerkinElmer's CE instruments cater to applications in pharmaceuticals, biotechnology, and clinical diagnostics. Their systems are known for their accuracy and ease of use.
Helena Biosciences: Helena Biosciences is a UK-based company that provides a range of CE systems and reagents for clinical diagnostics and hemoglobinopathy testing.
| Attribute | Details |
|---|---|
| Growth Rate | CAGR of 5.7% from 2023 to 2033 |
| Base Year of Estimation | 2023 |
| Historical Data | 2018 to 2022 |
| Forecast Period | 2023 to 2033 |
| Quantitative Units | Revenue in US$ billion and Volume in Units and F-CAGR from 2023 to 2033 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, growth factors, Trends, and Pricing Analysis |
| Key Segments Covered | Application, End-use Industry, By Region |
| Regions Covered | North America; Latin America; Europe; East Asia; South Asia; The Middle East & Africa; Oceania |
| Key Countries Profiled | United States, Canada, Brazil, Mexico, Germany, Italy, France, The United Kingdom, Spain, Russia, China, Japan, India, GCC Countries, Australia |
| Key Companies Profiled | Agilent Technologies; Bio-Rad Laboratories, Inc.; Helena Laboratories Corporation; Hoefer, Inc. (Harvard Biosciences); Merck KGaA; PerkinElmer Inc.; SCIEX; SERVA Electrophoresis GmbH; Thermo Fisher Scientific Inc.; Danaher Corporation; Shimadzu Corporation; Takara Bio, Inc.; TBG Diagnostic Ltd; Cleaver Scientific; QIAGEN N.V.; Eurogentec; Sebia Group; Analytik Jena; Lonza Group |
| Customization & Pricing | Available upon Request |
The primary consumer for capillary electrophoresis is the life sciences industry.
Some of the key players in the capillary electrophoresis market are Agilent Technologies, Thermo Fisher Scientific, and Dionex.
The market is estimated to secure a valuation of US$ 1.0 billion in 2023.
The market is estimated to reach US$ 1.8 billion by 2033.
The life sciences sector holds high revenue potential in the Capillary Electrophoresis Market.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Product Life Cycle Analysis 3.5. Supply Chain Analysis 3.5.1. Supply Side Participants and their Roles 3.5.1.1. Producers 3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers) 3.5.1.3. Wholesalers and Distributors 3.5.2. Value Added and Value Created at Node in the Supply Chain 3.5.3. List of Raw Material Suppliers 3.5.4. List of Existing and Potential Buyer’s 3.6. Investment Feasibility Matrix 3.7. Value Chain Analysis 3.7.1. Profit Margin Analysis 3.7.2. Wholesalers and Distributors 3.7.3. Retailers 3.8. PESTLE and Porter’s Analysis 3.9. Regulatory Landscape 3.9.1. By Key Regions 3.9.2. By Key Countries 3.10. Regional Parent Market Outlook 3.11. Production and Consumption Statistics 3.12. Import and Export Statistics 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2018 to 2022 4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Application, 2018 to 2022 5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Application, 2023 to 2033 5.3.1. Genomic DNA 5.3.2. Plasmid DNA 5.3.3. Fragment Analysis 5.3.4. RNA/mRNA Analysis 5.3.5. Others 5.4. Y-o-Y Growth Trend Analysis By Application, 2018 to 2022 5.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End User, 2018 to 2022 6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End User, 2023 to 2033 6.3.1. Research Organizations and Institutes 6.3.2. Pharmaceutical & Biotechnology Companies 6.3.3. Others 6.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022 6.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 7.1. Introduction 7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2018 to 2022 7.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033 7.3.1. North America 7.3.2. Latin America 7.3.3. Western Europe 7.3.4. Eastern Europe 7.3.5. South Asia and Pacific 7.3.6. East Asia 7.3.7. Middle East and Africa 7.4. Market Attractiveness Analysis By Region 8. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 8.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 8.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 8.2.1. By Country 8.2.1.1. U.S. 8.2.1.2. Canada 8.2.2. By Application 8.2.3. By End User 8.3. Market Attractiveness Analysis 8.3.1. By Country 8.3.2. By Application 8.3.3. By End User 8.4. Key Takeaways 9. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 9.2.1. By Country 9.2.1.1. Brazil 9.2.1.2. Mexico 9.2.1.3. Rest of Latin America 9.2.2. By Application 9.2.3. By End User 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Application 9.3.3. By End User 9.4. Key Takeaways 10. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. Germany 10.2.1.2. U.K. 10.2.1.3. France 10.2.1.4. Spain 10.2.1.5. Italy 10.2.1.6. Rest of Western Europe 10.2.2. By Application 10.2.3. By End User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Application 10.3.3. By End User 10.4. Key Takeaways 11. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. Poland 11.2.1.2. Russia 11.2.1.3. Czech Republic 11.2.1.4. Romania 11.2.1.5. Rest of Eastern Europe 11.2.2. By Application 11.2.3. By End User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Application 11.3.3. By End User 11.4. Key Takeaways 12. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. India 12.2.1.2. Bangladesh 12.2.1.3. Australia 12.2.1.4. New Zealand 12.2.1.5. Rest of South Asia and Pacific 12.2.2. By Application 12.2.3. By End User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Application 12.3.3. By End User 12.4. Key Takeaways 13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. China 13.2.1.2. Japan 13.2.1.3. South Korea 13.2.2. By Application 13.2.3. By End User 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Application 13.3.3. By End User 13.4. Key Takeaways 14. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Country 14.2.1.1. GCC Countries 14.2.1.2. South Africa 14.2.1.3. Israel 14.2.1.4. Rest of MEA 14.2.2. By Application 14.2.3. By End User 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Application 14.3.3. By End User 14.4. Key Takeaways 15. Key Countries Market Analysis 15.1. U.S. 15.1.1. Pricing Analysis 15.1.2. Market Share Analysis, 2022 15.1.2.1. By Application 15.1.2.2. By End User 15.2. Canada 15.2.1. Pricing Analysis 15.2.2. Market Share Analysis, 2022 15.2.2.1. By Application 15.2.2.2. By End User 15.3. Brazil 15.3.1. Pricing Analysis 15.3.2. Market Share Analysis, 2022 15.3.2.1. By Application 15.3.2.2. By End User 15.4. Mexico 15.4.1. Pricing Analysis 15.4.2. Market Share Analysis, 2022 15.4.2.1. By Application 15.4.2.2. By End User 15.5. Germany 15.5.1. Pricing Analysis 15.5.2. Market Share Analysis, 2022 15.5.2.1. By Application 15.5.2.2. By End User 15.6. U.K. 15.6.1. Pricing Analysis 15.6.2. Market Share Analysis, 2022 15.6.2.1. By Application 15.6.2.2. By End User 15.7. France 15.7.1. Pricing Analysis 15.7.2. Market Share Analysis, 2022 15.7.2.1. By Application 15.7.2.2. By End User 15.8. Spain 15.8.1. Pricing Analysis 15.8.2. Market Share Analysis, 2022 15.8.2.1. By Application 15.8.2.2. By End User 15.9. Italy 15.9.1. Pricing Analysis 15.9.2. Market Share Analysis, 2022 15.9.2.1. By Application 15.9.2.2. By End User 15.10. Poland 15.10.1. Pricing Analysis 15.10.2. Market Share Analysis, 2022 15.10.2.1. By Application 15.10.2.2. By End User 15.11. Russia 15.11.1. Pricing Analysis 15.11.2. Market Share Analysis, 2022 15.11.2.1. By Application 15.11.2.2. By End User 15.12. Czech Republic 15.12.1. Pricing Analysis 15.12.2. Market Share Analysis, 2022 15.12.2.1. By Application 15.12.2.2. By End User 15.13. Romania 15.13.1. Pricing Analysis 15.13.2. Market Share Analysis, 2022 15.13.2.1. By Application 15.13.2.2. By End User 15.14. India 15.14.1. Pricing Analysis 15.14.2. Market Share Analysis, 2022 15.14.2.1. By Application 15.14.2.2. By End User 15.15. Bangladesh 15.15.1. Pricing Analysis 15.15.2. Market Share Analysis, 2022 15.15.2.1. By Application 15.15.2.2. By End User 15.16. Australia 15.16.1. Pricing Analysis 15.16.2. Market Share Analysis, 2022 15.16.2.1. By Application 15.16.2.2. By End User 15.17. New Zealand 15.17.1. Pricing Analysis 15.17.2. Market Share Analysis, 2022 15.17.2.1. By Application 15.17.2.2. By End User 15.18. China 15.18.1. Pricing Analysis 15.18.2. Market Share Analysis, 2022 15.18.2.1. By Application 15.18.2.2. By End User 15.19. Japan 15.19.1. Pricing Analysis 15.19.2. Market Share Analysis, 2022 15.19.2.1. By Application 15.19.2.2. By End User 15.20. South Korea 15.20.1. Pricing Analysis 15.20.2. Market Share Analysis, 2022 15.20.2.1. By Application 15.20.2.2. By End User 15.21. GCC Countries 15.21.1. Pricing Analysis 15.21.2. Market Share Analysis, 2022 15.21.2.1. By Application 15.21.2.2. By End User 15.22. South Africa 15.22.1. Pricing Analysis 15.22.2. Market Share Analysis, 2022 15.22.2.1. By Application 15.22.2.2. By End User 15.23. Israel 15.23.1. Pricing Analysis 15.23.2. Market Share Analysis, 2022 15.23.2.1. By Application 15.23.2.2. By End User 16. Market Structure Analysis 16.1. Competition Dashboard 16.2. Competition Benchmarking 16.3. Market Share Analysis of Top Players 16.3.1. By Regional 16.3.2. By Application 16.3.3. By End User 17. Competition Analysis 17.1. Competition Deep Dive 17.1.1. Agilent Technologies Inc. 17.1.1.1. Overview 17.1.1.2. Product Portfolio 17.1.1.3. Profitability by Market Segments 17.1.1.4. Sales Footprint 17.1.1.5. Strategy Overview 17.1.1.5.1. Marketing Strategy 17.1.1.5.2. Product Strategy 17.1.1.5.3. Channel Strategy 17.1.2. Bio-Rad Laboratories Inc. 17.1.2.1. Overview 17.1.2.2. Product Portfolio 17.1.2.3. Profitability by Market Segments 17.1.2.4. Sales Footprint 17.1.2.5. Strategy Overview 17.1.2.5.1. Marketing Strategy 17.1.2.5.2. Product Strategy 17.1.2.5.3. Channel Strategy 17.1.3. Danaher Corp 17.1.3.1. Overview 17.1.3.2. Product Portfolio 17.1.3.3. Profitability by Market Segments 17.1.3.4. Sales Footprint 17.1.3.5. Strategy Overview 17.1.3.5.1. Marketing Strategy 17.1.3.5.2. Product Strategy 17.1.3.5.3. Channel Strategy 17.1.4. Helena Laboratories Corp. 17.1.4.1. Overview 17.1.4.2. Product Portfolio 17.1.4.3. Profitability by Market Segments 17.1.4.4. Sales Footprint 17.1.4.5. Strategy Overview 17.1.4.5.1. Marketing Strategy 17.1.4.5.2. Product Strategy 17.1.4.5.3. Channel Strategy 17.1.5. Lumex Instruments 17.1.5.1. Overview 17.1.5.2. Product Portfolio 17.1.5.3. Profitability by Market Segments 17.1.5.4. Sales Footprint 17.1.5.5. Strategy Overview 17.1.5.5.1. Marketing Strategy 17.1.5.5.2. Product Strategy 17.1.5.5.3. Channel Strategy 17.1.6. PerkinElmer Inc. 17.1.6.1. Overview 17.1.6.2. Product Portfolio 17.1.6.3. Profitability by Market Segments 17.1.6.4. Sales Footprint 17.1.6.5. Strategy Overview 17.1.6.5.1. Marketing Strategy 17.1.6.5.2. Product Strategy 17.1.6.5.3. Channel Strategy 17.1.7. Promega Corp 17.1.7.1. Overview 17.1.7.2. Product Portfolio 17.1.7.3. Profitability by Market Segments 17.1.7.4. Sales Footprint 17.1.7.5. Strategy Overview 17.1.7.5.1. Marketing Strategy 17.1.7.5.2. Product Strategy 17.1.7.5.3. Channel Strategy 17.1.8. QIAGEN NV 17.1.8.1. Overview 17.1.8.2. Product Portfolio 17.1.8.3. Profitability by Market Segments 17.1.8.4. Sales Footprint 17.1.8.5. Strategy Overview 17.1.8.5.1. Marketing Strategy 17.1.8.5.2. Product Strategy 17.1.8.5.3. Channel Strategy 17.1.9. SEBIA SA 17.1.9.1. Overview 17.1.9.2. Product Portfolio 17.1.9.3. Profitability by Market Segments 17.1.9.4. Sales Footprint 17.1.9.5. Strategy Overview 17.1.9.5.1. Marketing Strategy 17.1.9.5.2. Product Strategy 17.1.9.5.3. Channel Strategy 17.1.10. Thermo Fisher Scientific Inc. 17.1.10.1. Overview 17.1.10.2. Product Portfolio 17.1.10.3. Profitability by Market Segments 17.1.10.4. Sales Footprint 17.1.10.5. Strategy Overview 17.1.10.5.1. Marketing Strategy 17.1.10.5.2. Product Strategy 17.1.10.5.3. Channel Strategy 18. Assumptions & Acronyms Used 19. Research Methodology
Explore Testing Equipment Insights
View Reports
Capillary Electrophoresis Market
